思創醫惠:加速物聯網智慧醫療溯源管理項目落地實施 擬收購易捷醫療18%的股權
格隆匯2月9日丨思創醫惠(300078.SZ)公佈,為加快公司在物聯網醫療應用領域的佈局,加速公司募投項目“物聯網智慧醫療溯源管理項目”的落地實施,公司決定以自有資金5400萬元人民幣受讓寧波梅山保税港區惠瑞投資管理合夥企業(有限合夥)(“寧波惠瑞投資”)所持有的杭州易捷醫療器械有限公司(“標的公司”、“易捷醫療”)18%的股權。此次轉讓完成後,公司持有易捷醫療18%的股權。
公告顯示,易捷醫療經營範圍:銷售:第一類醫療器械、第二類醫療器械、計算機軟硬件、計算機輔助設備及配件、通訊設備、電子產品;經營貨物、技術進出口業務(國家法律法規禁止、限制的除外);技術開發、技術服務、技術諮詢、成果轉讓:計算機軟硬件、電子產品、通訊設備、醫療器械、計算機系統集成、計算機信息技術。(依法須經批准的項目,經相關部門批准後方可開展經營活動)
醫療是物聯網技術的重要應用領域。公司2018年度非公開發行股票募投項目之一“物聯網智慧醫療溯源管理項目”即是基於RFID技術以及物聯網共性開放平台,利用物聯網技術對醫用清潔物資進行自動識別、定位、監控和管理,為醫院提供國際領先的全流程閉環管理服務。
易捷醫療是一家專業從事醫療智能化器械設備研製生產的高新技術企業。易捷醫療的被服智能管理回收車等產品可為公司募投項目“物聯網智慧醫療溯源管理項目”提供硬件上的支持。投資易捷醫療,有助於公司募投項目的更快落地實施,提高募投項目的經濟效益。藉助標的公司的智能化醫療器械產品基礎和技術優勢,公司還可以進一步開拓醫療物資器械的全流程管理市場。因此,此次對外投資將有利於深化公司在醫療物聯網領域的戰略佈局,符合公司“互聯物聯,改變生活”的整體戰略目標。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.